On the Record · Parexel International
Parexel International acquisitions, on the record
The businesses Parexel International bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
Quantum Solutions India (QSI)Word for word“On April 13, 2015, we acquired all of the business assets of privately-owned Quantum Solutions India (“QSI”), a leading provider of specialized pharmacovigilance services, based in Chandigarh, India.” 10-K for 2015 | acquisition | April 13, 2015 | — |
ClinIntel Limited (ClinIntel)Word for word“On October 3, 2014, we acquired all of the outstanding equity securities of privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom.” 10-K for 2015 | acquisition | October 3, 2014 | — |
ATLAS Medical Services (ATLAS)Word for word“On July 1, 2014, we acquired all of the outstanding equity securities of ATLAS, a provider of clinical research services in Turkey, the Middle East, and North Africa, for approximately $ 2.1 million .” 10-K for 2015 | acquisition | July 1, 2014 | approximately $ 2.1 million |
HERON Group LTD (HERON)Word for word“On April 30, 2013, we acquired all of the outstanding equity securities of HERON Group LTD (“HERON”), a life sciences consultancy which provides evidence-based commercialization services to support biopharmaceutical companies throughout the lifecycle of their products.” 10-K for 2015 | acquisition | April 30, 2013 | — |
LIQUENT, Inc. (LIQUENT)Word for word“On December 21, 2012, we acquired all of the outstanding equity securities of LIQUENT, Inc. (“LIQUENT”), a leading global provider of RIM solutions for total cash consideration of $74.3 million .” 10-K for 2015 | acquisition | December 21, 2012 | $74.3 million |
ATLAS Medical ServicesWord for word“On July 1, 2014, we acquired all of the outstanding equity securities of ATLAS, a provider of clinical research services in Turkey, the Middle East, and North Africa, for approximately $ 2.1 million .” 10-K for 2016 | acquisition | July 1, 2014 | approximately $ 2.1 million |
ClinIntel LimitedWord for word“On October 3, 2014, we acquired all of the outstanding equity securities of privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom.” 10-K for 2016 | acquisition | October 3, 2014 | — |
Quantum Solutions IndiaWord for word“On April 13, 2015, we acquired all of the business assets of privately-owned Quantum Solutions India (“QSI”), a leading provider of specialized pharmacovigilance services, based in Chandigarh, India.” 10-K for 2016 | acquisition | April 13, 2015 | — |
Health Advances LLCWord for word“The acquisition closed on February 10, 2016 and is part of the PAREXEL Consulting Services (“PC”) segment.” 10-K for 2016 | acquisition | February 10, 2016 | — |
HERONWord for word“Our acquisition of HERON has strengthened our ability to offer our clients a full spectrum of services that aid in developing products through reimbursement and market access strategies.” 10-K for 2016 | acquisition | — | — |
ExecuPharm, Inc.Word for word“On October 3, 2016, we acquired all of the capital stock of privately owned ExecuPharm, Inc. ("ExecuPharm"), a leading global functional service provider, based in Pennsylvania.” 10-K for 2017 | acquisition | On October 3, 2016 | — |
The Medical Affairs Company, LLC (TMAC)Word for word“On March 1, 2017, we acquired all of the membership interests of privately owned The Medical Affairs Company, LLC ("TMAC"), a leading provider of outsourced medical affairs services to the pharmaceutical, biotechnology, and medical device industries.” 10-K for 2017 | acquisition | On March 1, 2017 | — |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) | Goodwill from acquisitions |
|---|---|---|
| 2016-06-30 | $67.3 million | $0 |
| 2017-06-30 | $184.6 million | — |
Deal filings since 2016
- 2017-09-29 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2017-06-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-03-02 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-02-23 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-12-23 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-11-22 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-03-17 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-02-17 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Parexel International’s annual reports (10-K for 2017, 10-K for 2016, 10-K for 2015) and the financial data it files with the SEC, as of 2017-08-29. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.